# reload+after+2024-01-21 11:45:04.425645
address1§Via Olgettina No. 58
city§Milan
state§MI
zip§20132
country§Italy
phone§39 02 26 43 46 81
website§https://www.genenta.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Pierluigi  Paracchi', 'age': 50, 'title': 'Vice Chairman of the Board, CEO & GM', 'yearBorn': 1973, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Luigi  Naldini M.D., Ph.D.', 'age': 64, 'title': 'Co-Founder & Chairman of the Executive Scientific Board', 'yearBorn': 1959, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Bernard Rudolph Gentner M.D., Ph.D.', 'age': 48, 'title': 'Co-Founder & Member of the Executive Scientific Board', 'yearBorn': 1975, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard B. Slansky', 'age': 65, 'title': 'Chief Financial Officer', 'yearBorn': 1958, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Carlo  Russo M.D.', 'age': 70, 'title': 'Chief Medical Officer & Head of Development', 'yearBorn': 1953, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stefania  Mazzoleni Ph.D.', 'age': 41, 'title': 'Director of Program Development', 'yearBorn': 1982, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Barbara  Regonini', 'title': 'Director of Finance', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.761
currency§USD
dateShortInterest§1702598400
forwardEps§-0.54
exchange§NCM
quoteType§EQUITY
shortName§Genenta Science S.p.A.
longName§Genenta Science S.p.A.
firstTradeDateEpochUtc§1639578600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§10554ac1-02bd-3307-8e63-2330484e6448
gmtOffSetMilliseconds§-18000000
targetHighPrice§25.0
targetLowPrice§21.0
targetMeanPrice§23.0
targetMedianPrice§23.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§13.631
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
